AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 285: E182-E188, 2003. First published March 25, 2003; doi:10.1152/ajpendo.00558.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/E182    most recent
00558.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, J. M.
Right arrow Articles by Vargas, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno, J. M.
Right arrow Articles by Vargas, F.

Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats

Juan Manuel Moreno, Rosemary Wangensteen, Juan Sainz, Isabel Rodríguez-Gomez, Virginia Chamorro, Antonio Osuna, and Félix Vargas

Departamento de Fisiología, Facultad de Medicina, Servicio de Nefrología, Unidad Experimental, Hospital Virgen de las Nieves, 118012 Granada, Spain

Submitted 19 December 2002 ; accepted in final form 18 March 2003

This study analyzed the role of nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) in the abnormal renal vascular reactivity of hypothyroid rats. Renal responses to vasoconstrictors [VC: phenylephrine (PHE) and ANG II] and vasodilators [VD: ACh, sodium nitroprusside (SNP), and papaverine (PV)] were studied in kidneys from control and hypothyroid rats under normal conditions and after NO or EDHF blockade. NO was blocked by the administration of N{omega}-nitro-L-arginine methyl ester (L-NAME) and EDHF by the administration of tetraethylammonium (TEA) or by an increased extracellular K+. The response to VC was also evaluated after endothelium removal. Hypothyroid kidneys showed reduced responsiveness to PHE and a normal response to ANG II. L-NAME and TEA administration produced an increased sensitivity to PHE and to ANG II in control preparations. L-NAME also increased the response to PHE in hypothyroid kidneys, but the differences between control and hypothyroid kidneys were maintained. TEA administration did not change the response to either VC in hypothyroid preparations. In endothelium-removed preparations, TEA was unable to increase pressor responsiveness to VC. Hypothyroid kidneys showed reduced responsiveness to ACh and SNP and normal response to PV. The differences between hypothyroid and control preparations in the responses to ACh and SNP were maintained after L-NAME or increased K+. In conclusion, this study shows that 1) the attenuated response to PHE in hypothyroidism is not related to an increased production of endothelium-derived relaxing factors NO and EDHF; 2) the response to VC in hypothyroid preparations is insensitive to EDHF blockade; and 3) hypothyroid preparations have a reduced reactivity to the NO donor, and NO-independent vasodilatation remains unaffected.

hypothyroidism; nitric oxide; endothelium-derived hyperpolarizing factor; vasoconstriction; vasodilatation



Address for reprint requests and other correspondence: F. Vargas, Departamento de Fisiología, Facultad de Medicina, E-18012, Granada, Spain (E-mail: fvargas{at}ugr.es).




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, M. Fortier, A. S. Greenberg, and M. S. Obin
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
J. Lipid Res., November 1, 2005; 46(11): 2347 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. A. Dinenno and M. J. Joyner
Combined NO and PG inhibition augments {alpha}-adrenergic vasoconstriction in contracting human skeletal muscle
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2576 - H2584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.